Neuromersiv

About

Neuromersiv develops a data-driven VR rehabilitation platform with proprietary hand and arm wearables for brain injury recovery, conducting clinical trials and partnering with rehabilitation centers and hospitals.

Mission

Neuromersiv builds a data-driven virtual reality rehabilitation platform paired with proprietary hand and arm wearables to improve engagement, compliance and outcomes for brain injury survivors. The company plans clinical trials in NSW public hospitals to gather independent evidence on efficacy and to position the product as a clinically validated, global therapy solution. Founded by Anshul Dayal, Oliver Morton-Evans and Rohan O’Reilly in late 2017, the team has progressed through accelerators including Muru-D, Cicada Medlab and Medtech Actuator. Neuromersiv has established commercial partnerships with Neuromoves (11 rehabilitation centres across Australia) and partnerships with hospitals in India and Taiwan, plus research collaborations with the University of Newcastle and Hunter Medical Research Institute. Industry advisors include senior rehabilitation experts such as Professor Michael Nilsson and Jodie Marquez. The company has previously received venture funding from Artesian and grant support from AusIndustry’s Accelerating Commercialisation program.

Quick Facts